Table 3.
Dilution in DMEM | |||||||
---|---|---|---|---|---|---|---|
Virus Lineage | Initial Preparation Infectivity (TCID50/mL) |
Units | 1:10 | 1:100 | 1:1000 | 1:10,000 | 1:100,000 |
B.1.1 (Non-VOC) | 4.28 × 105 | RNA copies/mL | 1.9 × 108 | 2.9 × 107 | 3.5 × 106 | 2.7 × 105 | 1.7 × 104 |
Ct value E gene | 15.7 | 18.7 | 22.0 | 26.1 | 30.4 | ||
B.1.1.7 (Alpha) | 2.85 × 105 | RNA copies/mL | 2.0 × 108 | 2.2 × 107 | 2.9 × 106 | 3.7 × 105 | 5.1 × 104 |
Ct value E gene | 15.7 | 19.1 | 22.3 | 25.6 | 28.7 | ||
B.1.351 (Beta) | 2.16 × 105 | RNA copies/mL | 2.6 × 108 | 3.1 × 107 | 3.4 × 106 | 5.2 × 105 | 6.9 × 104 |
Ct value E gene | 15.3 | 18.6 | 22.1 | 25.0 | 28.2 | ||
P.1 (Gamma) | 1.77 × 105 | RNA copies/mL | 2.1 × 108 | 3.9 × 107 | 5.3 × 106 | 5.8 × 105 | 5.5 × 104 |
Ct value E gene | 15.6 | 18.2 | 21.4 | 24.8 | 28.6 | ||
B.1.617.2 (Delta) | 4.64 × 104 | RNA copies/mL | 2.8 × 108 | 3.7 × 107 | 4.8 × 106 | 5.4 × 105 | 6.9 × 104 |
Ct value E gene | 15.1 | 18.3 | 21.5 | 25.0 | 28.2 | ||
Dilution in Saliva | |||||||
B.1.1 (Non-VOC) | 4.28 × 105 | RNA copies/mL | 2.2 × 108 | 2.4 × 107 | 2.6 × 106 | 2.7 × 105 | 2.7 × 104 |
Ct value E gene | 15.5 | 19.0 | 22.5 | 26.0 | 29.7 | ||
B.1.1.7 (Alpha) | 2.85 × 105 | RNA copies/mL | 1.6 × 108 | 1.4 × 107 | 1.9 × 106 | 2.3 × 105 | 2.5 × 104 |
Ct value E gene | 16.0 | 19.9 | 23.0 | 26.3 | 29.8 | ||
B.1.351 (Beta) | 2.16 × 105 | RNA copies/mL | 1.6 × 108 | 1.0 × 107 | 1.8 × 106 | ≈2 × 105 * | ≈2 × 104 * |
Ct value E gene | 16.0 | 20.3 | 23.1 | N.A. | N.A. | ||
P.1 (Gamma) | 1.77 × 105 | RNA copies/mL | 2.1 × 108 | 2.4 × 107 | 3.1 × 106 | 3.9 × 105 | 4.1 × 104 |
Ct value E gene | 15.6 | 19.0 | 22.2 | 25.5 | 29.0 | ||
B.1.617.2 (Delta) | 4.64 × 104 | RNA copies/mL | 1.8 × 108 | 2.1 × 107 | 2.3 × 106 | 2.8 × 105 | 3.8 × 104 |
Ct value E gene | 15.9 | 19.3 | 22.7 | 26.0 | 29.1 |
Ct: cycle threshold; NA: not available; E gene: envelope-protein gene E. * Estimated values based on the 1:1000 dilution step, due to invalid PCR results for the B.1.351 dilution steps 1:10,000 and 1:100,000 in saliva (consistency of the B.1.351 dilution series in saliva was verified in a separate PCR, repeated with the EDX SARS-CoV-2 standard (Exact diagnostics) after 24 h).